Citations (28)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Chawanphat Muangnoi, Ponsiree Jithavech, Pahweenvaj Ratnatilaka Na Bhuket, Wiwat Supasena, Wisut Wichitnithad, Pasarapa Towiwat, Nuansri Niwattisaiwong, Ian S. Haworth & Pornchai Rojsitthisak. (2018) A curcumin-diglutaric acid conjugated prodrug with improved water solubility and antinociceptive properties compared to curcumin. Bioscience, Biotechnology, and Biochemistry 82:8, pages 1301-1308.
Read now
Read now
Articles from other publishers (27)
Mark A Giembycz & Donald H Maurice. (2014) Cyclic nucleotide-based therapeutics for chronic obstructive pulmonary disease. Current Opinion in Pharmacology 16, pages 89-107.
Crossref
Crossref
Richard B. Silverman & Mark W. Holladay. 2014. The Organic Chemistry of Drug Design and Drug Action. The Organic Chemistry of Drug Design and Drug Action
423
468
.
Joachim A. Stellmach. (2009) The influences of the structure and activity of biologically active compounds on the assessment of inventive step. World Patent Information 31:3, pages 226-234.
Crossref
Crossref
Bernard Testa & Stefanie D. Krämer. (2009) The Biochemistry of Drug Metabolism – An Introduction. Chemistry & Biodiversity 6:5, pages 591-684.
Crossref
Crossref
Alain Trachsel, Jean-Yves de Saint Laumer, Olivier P. Haefliger & Andreas Herrmann. (2009) Parameters Influencing the Release of Tertiary Alcohols from the Surface of “Spherical” Dendrimers and “Linear” Stylomers by Neighbouring-Group-Assisted Hydrolysis of 2-Carbamoylbenzoates. Chemistry - A European Journal 15:12, pages 2846-2860.
Crossref
Crossref
Rafik Karaman. (2009) A new mathematical equation relating activation energy to bond angle and distance: A key for understanding the role of acceleration in lactonization of the trimethyl lock system. Bioorganic Chemistry 37:1, pages 11-25.
Crossref
Crossref
Yu Chen & Longqin Hu. (2008) Design of anticancer prodrugs for reductive activation. Medicinal Research Reviews 29:1, pages 29-64.
Crossref
Crossref
Alain Trachsel, Alexandra Govoni, Jean‐Yves de Saint Laumer, Eric Frérot & Andreas Herrmann. (2008) Controlled Release of Volatile Secondary and Tertiary Alcohols by Neighboring Group Participation: Stepwise Cyclization and Re‐Opening of 2,2′‐Bis(carbamoyl)dibenzoates at Neutral pH. Chemistry & Biodiversity 5:12, pages 2621-2639.
Crossref
Crossref
Bernard Testa. 2008. Drug Bioavailability. Drug Bioavailability
559
570
.
Paula Gomes, Nuno Vale & Rui Moreira. (2007) Cyclization-activated Prodrugs. Molecules 12:11, pages 2484-2506.
Crossref
Crossref
Andreas Herrmann. (2007) Controlled Release of Volatiles under Mild Reaction Conditions: From Nature to Everyday Products. Angewandte Chemie International Edition 46:31, pages 5836-5863.
Crossref
Crossref
Andreas Herrmann. (2007) Kontrollierte Freisetzung flüchtiger Verbindungen unter milden Reaktionsbedingungen: von der Natur zu Alltagsprodukten. Angewandte Chemie 119:31, pages 5938-5967.
Crossref
Crossref
B. Testa. 2007. Comprehensive Medicinal Chemistry II. Comprehensive Medicinal Chemistry II
1009
1041
.
Richard B. Greenwald & Hong Zhao. 2007. Prodrugs. Prodrugs
283
338
.
Jeffrey P. Krise & Reza Oliyai. 2007. Prodrugs. Prodrugs
801
831
.
Graham S. Poindexter, Yadagiri Pendri, Lawrence B. Snyder, Joseph P. Yevich & Milind Deshpande. 2007. Kent and Riegel’s Handbook of Industrial Chemistry and Biotechnology. Kent and Riegel’s Handbook of Industrial Chemistry and Biotechnology
404
430
.
P. Jeschke & R. Nauen. 2005. Comprehensive Molecular Insect Science. Comprehensive Molecular Insect Science
53
105
.
Bernard Testa. (2004) Prodrug research: futile or fertile?. Biochemical Pharmacology 68:11, pages 2097-2106.
Crossref
Crossref
Richard B. Silverman. 2004. The Organic Chemistry of Drug Design and Drug Action. The Organic Chemistry of Drug Design and Drug Action
497
557
.
Thorsten A. Kirschberg, Chris L. VanDeusen, Jonathan B. Rothbard, Michael Yang & Paul A. Wender. (2003) Arginine-Based Molecular Transporters: The Synthesis and Chemical Evaluation of Releasable Taxol-Transporter Conjugates. Organic Letters 5:19, pages 3459-3462.
Crossref
Crossref
Jean‐Yves de Saint Laumer, Eric Frérot & Andreas Herrmann. (2003) Controlled Release of Perfumery Alcohols by Neighboring‐Group Participation. Comparison of the Rate Constants for the Alkaline Hydrolysis of 2‐Acyl‐, 2‐(Hydroxymethyl)‐, and 2‐Carbamoylbenzoates. Helvetica Chimica Acta 86:8, pages 2871-2899.
Crossref
Crossref
Joseph A. Fuselier, Lichun Sun, S.Nathaniel Woltering, William A. Murphy, Natalya Vasilevich & David H. Coy. (2003) An adjustable release rate linking strategy for cytotoxin–Peptide conjugates. Bioorganic & Medicinal Chemistry Letters 13:5, pages 799-803.
Crossref
Crossref
Donald J. AbrahamBernard Testa & William Soine. 2003. Burger's Medicinal Chemistry and Drug Discovery. Burger's Medicinal Chemistry and Drug Discovery
431
498
.
Richard B. Greenwald, Yun H. Choe, Jeffrey McGuire & Charles D. Conover. (2003) Effective drug delivery by PEGylated drug conjugates. Advanced Drug Delivery Reviews 55:2, pages 217-250.
Crossref
Crossref
James A. Kent. 2003. Riegel's Handbook of Industrial Chemistry. Riegel's Handbook of Industrial Chemistry
1073
1097
.
R.B Greenwald. (2001) PEG drugs: an overview. Journal of Controlled Release 74:1-3, pages 159-171.
Crossref
Crossref
Richard B. Greenwald, Yun H. Choe, Charles D. Conover, Kwok Shum, Dechun Wu & Maksim Royzen. (2000) Drug Delivery Systems Based on Trimethyl Lock Lactonization: Poly(ethylene glycol) Prodrugs of Amino-Containing Compounds. Journal of Medicinal Chemistry 43:3, pages 475-487.
Crossref
Crossref